
About Chemist180
Chemist180 is a Healthcare company based in Ahmedabad (India) founded in 2020 by Sunny Shah. It operates an online pharmacy specializing in generic medicines and healthcare products. It operates on a B2C model. The company has 19 employees. Its website chemist180.com draws about 98 thousand monthly visits. Its Indian entity Chemist180 Epharmacy Private Limited reported revenue of βΉ66.1 Lakh. Its focus areas include Pharmaceuticals, E-commerce Pharmacy and Generic Medicines. Similar companies include Tata 1mg, Netmeds, Truemeds, PharmEasy and MedPlus and 4 more; 8 of its 9 listed similar companies have raised funding.
Company details
Chemist180, founded in 2020 in Ahmedabad, India, focuses on providing healthcare solutions, producing pharmaceutical products, e-commerce pharmacy, and generic medicines. Operates an online pharmacy specializing in generic medicines and healthcare products. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Ahmedabad, India
- Employees 19
- Founders Sunny Shah
- SectorsHealthcare
- Website chemist180.com
- Social Facebook
- Legal Name Chemist180 Epharmacy Private Limited
- Date of Incorporation 31 Dec, 2019
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹66.1 Lakh
FY 2024 · -1% YoY
- Net Loss-₹14.5 Lakh
FY 2024 · -22% margin
- EBITDA-₹14.3 Lakh
FY 2024 · -22% margin
- Employee Count19
Associated legal entities of Chemist180
Chemist180 operates through Chemist180 Epharmacy Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Chemist180 Epharmacy Private Limited CIN U52310GJ2019PTC111779 | Active | 31 Dec 2019 | Ahmedabad, Gujarat | ₹0.7 Cr | 19 | 2 | View details |
Board of directors of Chemist180 Epharmacy Private Limited (Chemist180)
Chemist180 Epharmacy Private Limited is the primary company behind Chemist180. The board of Chemist180 Epharmacy Private Limited currently have 2 directors; the longest-serving is Prafulkumar Jethalal Shah, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prafulkumar Jethalal Shah DIN 08654865 | Director | 31 Dec 2019 | 6 yrs 9 mo | Chemist180 Epharmacy Private Limited |
| Sunny Prafulbhai Shah DIN 08654866 | Director | 31 Dec 2019 | 6 yrs 9 mo | Chemist180 Epharmacy Private Limited |
People of Chemist180
1 people are tracked at Chemist180 (1 in leadership); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership |
Complete people profiles for Chemist180
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Chemist180
Figures of Chemist180 Epharmacy Private Limited, the primary company behind Chemist180, for FY 2024. Revenue was ₹66.1 Lakh (-1% year on year). Net loss was -₹14.5 Lakh (-22% margin). EBITDA was -₹14.3 Lakh (-22% margin). Revenue has grown at a compounded annual rate of +32% over three years.
- ₹66.1 LakhRevenue · FY 2024 · -1% YoY
- -₹14.5 LakhNet loss · -22% margin
- -₹14.3 LakhEBITDA · -22% margin
- ₹1 LakhPaid-up capital
- 19Employees (provident fund records)
- +32%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Chemist180 Epharmacy Private Limited are on its company page.
Detailed financial statements for Chemist180
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Chemist180
Chemist180 has 9 listed similar companies in our database, 8 of them funded. They include Tata 1mg, Netmeds, Truemeds, PharmEasy and MedPlus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 1mg.com | 2015 | Delhi, India | $230.8M | 4,419 | Provider of an online pharmacy with doctor listing and teleconsultation services | |
| netmeds.com | 2015 | Chennai, India | $109M | 988 | Provider of an online store for medicines and healthcare products | |
| truemeds.in | 2019 | Mumbai, India | $112.97M | 345 | Provider of an online pharmacy and telehealth platform | |
| pharmeasy.in | 2015 | Mumbai, India | $688.41M | 493 | Provider of an online pharmacy and healthcare platforms | |
| medplusindia.com | 2006 | Hyderabad, India | $268.78M | 8,729 | Medicines and health products are retailed through pharmacy outlets. | |
| sastasundar.com | 2011 | Kolkata, India | $38.26M | 1,344 | An online marketplace for healthcare products is operated. | |
| medlife.com | 2014 | Bengaluru, India | – | 46 | Provider of an online pharmacy for medications | |
| tablt.com | 2018 | Kolkata, India | $8.28M | 144 | Online platform for the purchase of medicines | |
| healthskoolpharmacy.com | 2015 | Noida, India | $3.32M | 111 | Online pharmacy for the delivery of OTC and prescription medicines |
Detailed similar companies of Chemist180
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Chemist180
The website of Chemist180 (chemist180.com) receives about 98.4K visits a month.
- Monthly visits98.4K
▼ 16.8% vs previous month
Websites whose visitors overlap most with Chemist180. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| oilatum.co.uk | 100% | 8.2K | – | View details | |
| platinumrx.in | 94% | 1.4M | #61,787 | View details | |
| sebamedindia.com | 93% | 46.9K | #665,109 | View details | |
| tablt.com | 91% | 16.1K | #1,785,040 | View details | |
| retailershakti.com | 90% | 188.9K | #204,331 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 24 similar websites and full traffic analytics for Chemist180
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Chemist180 (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Chemist180
Chemist180 was founded in 2020.
Chemist180 is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Chemist180 has 19 employees.
The primary company behind Chemist180, Chemist180 Epharmacy Private Limited, reported revenue of βΉ66.1 Lakh for FY 2024, down 1% year on year.
Chemist180, founded in 2020 in Ahmedabad, India, focuses on providing healthcare solutions, producing pharmaceutical products, e-commerce pharmacy, and generic medicines. Operates an online pharmacy specializing in generic medicines and healthcare products. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Chemist180's top competitors include Tata 1mg, SastaSundar and PharmEasy.
Chemist180 operates through Chemist180 Epharmacy Private Limited.
The legal entities of Chemist180 currently have 2 directors, including Prafulkumar Jethalal Shah, Sunny Prafulbhai Shah.